Moreover, the results of transwell migration and invasion assays revealed that knockdown of LOXL1-AS1 dramatically inhibited osteosarcoma cell migration and invasion abilities in U-2 OS and Saos-2 cells (P<0.001, Figure 3D,E). The gene discussed is LOXL1; the disease is osteosarcoma.